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Abstract 
The discovery of an organic component in kidney 
stones dates back to 1684. More than 150 years elapsed 
before the incrustation of this organic component, which 
is now called the matrix, was proposed as the mecha-
nism of stone formation. The composition of the matrix 
remained largely unknown until the development of elec-
tron microscopy and the advances in biochemistry com-
bined in the 1950's to usher in the modern era of renal 
stone matrix investigation. Composed mainly of selec-
tively incorporated proteins generally characterized by 
high glutamic and aspartic acid content and the frequent 
occurrence of -y-carboxyglutamic acid, the matrix dis-
plays a variable and complex composition and shares a 
few proteins in many stones. The embryonic stone may . 
first appear in the renal tubules where it can acquire the 
blood and cell membrane proteins recently found by 
analysis of stone protein extracts. The combination of 
supersaturation, an appropriate environment, the avail-
ability of calcium binding proteins which may be abnor-
mal, and the incorporation of proteins extracted from 
leukocytes and cell wall membranes may induce stone 
formation. 
Key Words: Stone, extraction, two-dimensional elec-
trophoresis, protein, amino acid, sequence. 
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Introduction 
The discovery that the "stone, " a long known source 
of torment for humankind, has an organic component 
dates back to 1684 when Von Hyde found that the calcu-
lus has an organic framework which we now call the 
matrix [5]. The following century was remarkably silent 
on this mundane topic until 1780 [26), when scientists 
began to name and classify the organic components of 
stones and eventually suggested incrustation of such as 
the mechanism of stone formation [5]. 
Another century elapsed before Boyce, combining 
the advances in electron microscopy and biochemistry, 
brought the investigation of the organic component (ma-
trix) into the modern era. Other research groups have 
further expanded knowledge of the field and have pro-
gressively unravelled the composition of the matrix, 
identifying many of its protein components. What fol-
lows is an account of this collective effort spanning 
some 40 years and includes our unpublished work. It is 
presented in the form of tables accompanied by a textual 
commentary and key references. 
Materials and Methods 
Urinary and gallbladder stones obtained at surgery 
or postmortem were stored at 4 °C until the proteins 
were extracted. Sodium azide was used as a preserva-
tive. The stones were pulverized and the extraction was 
performed in the model 1750 ISCO (Lincoln, NE) appa-
ratus, originally devised to elute proteins from gels. 
0.05 M sodium citrate buffer with a pH of 6.0 was 
cooled by a refrigerated circulator with the current be-
tween 6.0-7.0 mA and the wattage at 3 W. Electrodial-
ysis was continued until the readings at 280 nm were 
negligible [1, 2). The extracts were pooled, concen-
trated and dialyzed against reverse osmosis distilled 
water, passed through an AcA44 column (IBF Biotech-
nics, Villeneuve-la-Garenne, France) employing Tris 
glycine buffer (0.023 M Tris, 0.008 M glycine adjusted 
to a pH of 8.2 with standardized 1 N HCl). The eluents 
were separated by their optical densities at 280 nm, con-
centrated after dialysis and lyophilized. Aliquots were 
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screened by isoelectric focusing (IEF) (FMC Biopro-
ducts, Rockland, ME) using the Hoefer cooling platen 
(Hoefer Scientific Instruments, San Fernando, CA) to 
ensure suitability for two-dimensional (2-D) electro-
phoresis (method of O'Farrell) [2]. Briefly, IEF was 
carried out in glass tubes (2.0 mm inner diameter) using 
2.0% Resolytes pH 4.8 ampholines. Tropomyosin was 
the internal standard: lower spot of molecular weight 
(MW) 33 kD and isoelectric point (pl) 5.2. 
After 10 minutes in buffer "O" {10% glycerol, 50 
mM dithiothreitol, 2.3 % sodium dodecylsulfate (SDS) 
and 0.0625 M tris; pH 6.8}, the tubes were sealed to the 
top of stacking gels which were on top of 10 % acryl-
amide slab gels (0.075 mm thick), and SDS slab gel 
electrophoresis was carried out for 4 hours at 12.5 
mA/gel. The following protein standards were used: 
myosin (220 kD); phosphorylase A (94 kD); catalase (60 
kD); actin (43 kD); carbonic anhydrase (29 kD) ; and 
lysozyme (14 kD). These standards appear as horizontal 
lines when stained with Coomassie Brilliant Blue R-250. 
The electrophoresed gels were transblotted onto PVDF 
(polyvinylidene disulfide membranes, immobilin Milli-
pore; Millipore Corp., Bedford, MA) overnight at 4°C 
in 12.5 mM tris, pH 8.8 , 86 mM glycine and 10% 
methanol at 200 mA, approximately 100 volts per gel. 
Membranes were stained with 0.1 % Coomassie blue in 
50 % methanol, rinsed four times in ultrapure distilled 
water and spots were marked, excised and sequenced on 
an Applied Biosystems (Foster City, CA) 470A gas 
phase sequencer/20PTH analyzer for NHrterminal 
sequence, 20 cycles were run on each. 
Results and Discussion 
Not surprisingly, the first proteins extracted from 
stones by Boyce and his associates included albumin and 
Tamm-Horsfall protein (THP) [33], the two most abun-
dant urinary proteins, as well as other proteins simply 
classified by their electrophoretic mobility as a-globulins 
and ;--globulins [4]. Boyce realized that incorporation 
of proteins into stones is a selective process, an observa-
tion repeatedly confirmed [6]. Dialysis against ethylene-
diaminetetraacetic acid (EDT A) containing solutions had 
been used to remove most of the crystalline component 
of the stones, leaving a matrix which proved difficult to 
solubilize. This prompted the use of immunological 
methods in Boyce's early work. 
The most immunologically abundant protein extract-
ed from stones he called substance A, a protein char-
acterized by a relatively high content of glutamic and 
aspartic acids, a characteristic shared by other proteins 
subsequently recovered from stones [3]. Moore and 
Gowland [19], in a later study, were unable to confirm 
the immunological oneness of substance A and, like 
Boyce et al. [3], could not detect it in normal urine, 
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only in the urine of stone formers and in some patholog-
ical conditions [19]. Matrix substance A, because of its 
reported large contribution to stone matrix composition, 
is likely to have been revisited by subsequent investiga-
tors. Unfortunately, more than one characterized pro-
tein has an isoelectric point around 4.5 and a molecular 
weight between 30-40 kD [20]. The identity of matrix 
substance A may therefore remain enigmatic. 
Boyce [4] had also reported the absence ofhydroxy-
proline and hydroxylysine on amino acid analysis of ma-
trix proteins and had suggested that the matrix of all uri-
nary calculi is similar irrespective of crystalline compo-
sition. This assertion was reexamined by Spector et al. 
[29] who analyzed calcium oxalate, uric acid and apatite-
struvite stones and confirmed the important contribution 
of aspartic and glutamic acids, but reported a distinct 
protein composition of the matrix of these stones. The 
following year, Lian et al. [17] reported that ;--carboxy-
glutamic acid (OLA) is present in the proteins of calci-
um containing stones, thus linking stone matrix proteins 
with bone and blood clotting, calcium-binding proteins. 
The resolution of kidney stone matrix proteins was 
expanded by Sugimoto et al. [31] who used high per-
formance liquid chromatography to separate EDTA ex-
tracts of stones, but did not characterize their proteins 
beyond ranges of molecular weights and concluded that 
the matrix protein composition is identical in all stones. 
Fraij [9] reached the same conclusion after separating 
SDS-solubilized matrix proteins by SDS gel electropho-
resis, although the amounts of each major protein com-
ponent, THP and albumin fluctuated widely. No protein 
of molecular weight around 90 kD was reported by 
Sugimoto et al. [31] while THP (94 kD) was one of the 
major proteins identified by Fraij [9]. These discrepan-
cies, likely the result of different methodologies (or pos-
sibly geography), continue to the present. 
One well-characterized protein, 6-2M (or fragments 
thereof), is the major constituent of matrix kidney stones 
recovered from uremic patients [ 18] and also the precur-
sor protein of the amyloid associated with long-term he-
modialysis [10] . The formation of this stone matrix, 
which displays the ultrastructure and the birefringence of 
amyloid, is reportedly independent of dialysis, while the 
amyloid which may be deposited elsewhere in the body, 
particularly the joints, appears only after years of dial-
ysis and is made of intact 6-2M [11]. Soluble proteins 
have also been extracted from these stones but not inves-
tigated further. One of these soluble proteins is likely 
amyloid P-component which has been found to accom-
pany all forms of amyloid and reportedly shields it from 
attack by proteolytic enzymes [35] . Such stones would 
provide a fine opportunity to examine the relationship of 
the amyloid fibril and the P-component and test the sus-
ceptibility of the matrix stone to proteolytic digestion 
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before and after removal of the P-component. 
Remarkably, two serine proteases along with hemo-
globin have been reported in formic acid extracted pro-
teins of calcium-containing stones [25]. This suggests a 
close encounter between crystals, red cells and neutro-
phils in the history of stone formation, with the cells 
leaving their signatures in stone to record the event. 
This injurious encounter may have occurred in the tu-
bule, in which case, other proteins derived from cells 
lining the tubules would be expected at the center of the 
stone early in its formation. Could these proteolytic 
enzymes remain active and participate in stone formation 
and could their activity be demonstrated after extraction? 
Nephrocalcin, the celebrated and shrouded protein, 
may be an example of a deficient protein, as extracted 
from stones and the urine of stone formers, possibly less 
able to bind calcium because of reduced -y-carboxylation 
of glutamic acid [23, 24, 34). The mechanism of the 
GLA deficiency in nephrocalcin remains unknown but 
has not been reported to be vitamin-K responsive nor 
warfarin inducible, although osteocalcin reportedly is 
[16). A recent N-terminal amino acid sequence identi-
fies nephrocalcin with a light chain of inter-alphatrypsin 
inhibitor [34), however, the absence of GLA and the 
lack of homology with osteocalcin suggest that authentic 
nephrocalcin remains to be sequenced. 
Another stone-extracted protein, an important con-
stituent of calcium oxalate monohydrate stones, uropon-
tin, shares the same amino acid sequence as osteopontin 
of bone and kidney, is rich in acidic amino acids but 
lacks -y-carboxyglutamic acid [13) . It inhibits calcium 
oxalate crystal growth in vitro, suggesting a shared in 
vivo role in the complex process of mineralization. Uro-
pontin may be an example of a protein exhibiting differ-
ent behaviors in different pH environments or following 
post-translational modifications such as phosphorylation 
[28) . Elucidation of its precise function remains a 
challenge. 
Tamm-Horsfall protein, another major constituent of 
kidney stone matrix proteins, isolated from urine in 1950 
[33) and subsequently extracted from calcium oxalate 
stones by Boyce [4], has been studied extensively but its 
function remains elusive. It appears to be a chameleon 
protein which may function as a promoter of crystalliza-
tion when exposed to low pH solutions or in the pres-
ence of cations such as calcium, magnesium or sodium 
[12). Self-aggregation ofTHP, which may be increased 
in stone formers, may also increase viscous binding neu-
tralizing the zeta potential of the electrostatic surface 
charge. If conditions are reversed to high pH and low 
concentrations of calcium and sodium, THP is trans-
formed into an inhibitor of calcium oxalate crystal ag-
gregation. The ability of citrate to preferentially bind 
calcium may thus explain its beneficial role in the pre-
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vention of calcium oxalate stone formation [12). 
Several proteins were added to this list using 2-D 
electrophoresis of proteins recovered after the dissolution 
of crystals formed in urine [22) or after formic acid ex-
traction from stones [14]. Most of these proteins have 
not been characterized beyond the determination of iso-
electric point and molecular weight but two interesting 
findings have emerged from this work: many low molec-
ular weight proteins have been recovered and important 
differences in electrophoretic patterns can be observed 
between proteins obtained from crystals and proteins ex-
tracted from stones, suggesting caution in the interpreta-
tion of results obtained from a vivo experiments [14, 
21, 22). The possibility of artifacts induced by the stone 
protein extraction procedure or protein degradation dur-
ing stone formation or tubular wall injury may explain 
the large presence of low molecular weight proteins. 
The discovery of a truncated a-1 antitrypsin in a 4 
M guanidine extract of calcium oxalate stones matches 
proteases discovered earlier in the same stones with the 
most abundant protease inhibitor in human serum [36] . 
Both enzyme(s) and inhibitor(s) may derive from leuko-
cytes that were attracted to these foreign crystal forma-
tions and lost some of their baggage in the encounter 
[8]. The connection of blood and stone has been more 
precisely documented by the isolation from calcium oxa-
late crystals and stones of a protein which binds calcium 
avidly , is a potent inhibitor of calcium oxalate crys-
tallization in vitro and shares the N-terrninal amino acid 
sequence of a prothrombin fragment recently identified 
as Fl [30) . Its presence in crystals and stones enhances 
its credentials as a player in stone formation. It also 
raises, more pertinently, the importance of the post-
translational carboxylation of specific glutamic acid resi-
dues required for the binding of calcium and the biologi-
cal activity of prothrombin, a vitamin K dependent func-
tion, again raising the question of the role of vitamin K 
and its inhibition by warfarin in the formation of stones. 
Blood and stones are again linked by a calprotectin-
like protein extracted from calcium oxalate stones and 
originally recruited from neutrophils and macrophages 
losing weight from 36.5 kD to 30 kD in the process 
[37]. The abundance of the protein in stones and its in-
hibitory potency on calcium oxalate crystal growth again 
suggest a role in mineralization which remains to be 
determined. 
The complex protein composition of stone matrix 
has been further expanded by the use of electrodialysis 
to extract proteins from crushed urinary tract stones and 
gallstones, followed by 2-D electrophoresis and selective 
N-terminal amino acid microsequencing [l, 2). The re-
sults, not previously reported, are presented in Table 1 
which includes many protein sequences not found in the 
data bank as well as several proteins originating from 
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Table 1. Stone sequences. Individual specimens are listed alphabetically with chemical composition, type of stone, 
pl (isoelectric point), approximate molecular weight (in kD), and N-terminal sequence. All specimens were examined 
by crystallography, polarized light and electron microscopy. 
No Type & Chemical pl App N-Tenninal Sequence Status:j: 
Composition MW 
(kD) 
A. kidney stone 5.4 40 AVVGGGATLPEKLYGST Unknown• A56049 
Urate calcium oxalate 5.1 32 DPGSATDYRTAAVGSDT Unknown - closest 
homology 
thrombospondin - PIR2 
Accession C56046 
4.9 30 XXQGAVEGELFYKKQYNDSV Root adhesion protein 
4.5 17 Blocked: Tryptic digest: 
(Y)L VLQGVAPG(Q)LXLV U nk.nown - PIR2 
Accession B56046 
5.6 42 (T)HSYFNDLAAETD U nk.nown - PIR2 
Accession H56046 
5.7 44 TNTLRPNFAETAK Unknown - PIR2 
Accession G56046 
4.7 21.5 AFELPPLPYAHDALQPHTSK Closest homology -
E56049 
Superoxide dismutase 
B. kidney stone 5.4 40 AVVGGGATLPEKLYGST U nk.nown - PIR2 
UrCaOx 5.1 32 N-tenninal Accession A56049 
DPGSATDYRTYAAVGSDT Accession C56046 
C. kidney stone 5.4 40 AVVGGGATLPEKLYGST Unknown - • 
4.75 22 AEYVLPDLA YDYGALEX(H)I Superoxide dismutase 
C56049 
4.5 17 Blocked NH terminal (Y)L VLQGV APG 
•B56046 (Q)LXLV 
4.7 21.5 AFELPPLPYAHDALQPHTSK Closest homology 
Superoxide dismutase 
4.8 23 AFELPPLPY AHDALQPHTSK Superoxide dismutase 
4.8 29 (Q)GQGA VEGELFYKKQYNDSV Root adhesion protein 
5.0 31 XXXXDL TIAKYDADLFAA Unknown - PIR2 
Accession E56046 
D. kidney stone 5.9 40 A VVGGGATLPEKL YG(S)T Unknown - PIR2 
Urate calcium oxalate Accession A56049 - • 
5.1 32 DPGSATDYRTYAAVGSDT Unknown - PIR2 
Accession C56046 
47.7 GTVTTDGADIVVKTKG Porin-P; 1 exception 
residue is at V 
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01 . kidney stone 5.1 32 DPGSATDYRTYAAVGSDT Unknown - closest 
Urate calcium oxalate C56046 
E. kidney stone 6.0 41.5 NDQEQSKGFVED(S)X Unknown - PIR2 
Urate calcium oxalate Accession E56049 
5.2 32.5 KDYELLNVSYD(P)T(R)EL Y (Q) Closest homology 
D56049 
Sulfate binding protein 
4.7 21.5 AFELPPLPY AHDALQPHIS Superoxide dismutase 
F. Urate calcium oxalate < 4.5 14 TQSLHYSSPRETL TDTIMAA Unknown - Tyrosine 
kidney stone related - PIR2 
Accession F56046 
MLQSQLSQ(T)D-tryptic digest Unknown - PIR2 
Accession D56046 
G. Urate calcium oxalate 5.9 40 A VVGGGATLPEKL YG(S)T Unknown - • 
H. Urate calcium oxalate 5.9 40 A VVGGGATLPEKL YG(S)T Unknown - • 
... 115 mg stone (AcA34) 5.4 40 A VVGGGATLPEKL YS(S)T Unknown 
kidney stone 27 HTDLSGKVFVFPRESVTDHV Serum amyloid P-
component (SAP) 
UrCaOx 27 HTDLSGKVFVFPRESVTDHV Serum amyloid 
p-component (SAP) 
(R)TPEVTXVVVDV lg gamma-x+C 
RTPEVTXVVVDV lg gamma chain 
J . kidney stone 4.8 < ASGNVKFfGEIVQSTXKV Unknown 
(UrCaOx) 18 
K. kidney stone 5.65 43 MIINHNIAALNTYNRLSAN (N) Similar to flagellin in 
B-subtilis 
5.5 33.5 AEIYNKDGNKLDL YGKVDAR 
4.65 21 MFSIPEQFSSATKTNLEAQF Unknown - PIR2 
Accession A56046 
< 4.5 14 MLQSQLSQTPRLALADTVl(D) Unknown - PIR2 
Accession D56046 
L. CaOx, monohydrate = 18% 5.4 33 AEIYNKDGNKLDL YGKIDG Outer membrane 
MgNH2P04 = 1 % ; CaOx protein 
dihydrate = 64% ; CaP04 5.5 33.5 AEVYNKDGNKLDLYGKVTA Outer membrane 
(carbonate) = 6%; CaP04 protein similar to Porin 
(hydroxyl form) = 7% ; P-differs at 18-19 
Protein & bl = 15% 
kidney stone 5.5 33.5 AEIYNKDGNKLDFYGKV 2: 1 lower = upper 
< 4.5 MLQSQLSQTPRLALADTV (l)D minus 3 NH terminal 
SQLSQTPRLALADTV(I) residues 
D56046 
< 4.5 14 TQSLHYSSPRETL TDTIMAA Unknown - F56046 
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M. Urate - CaOx < 4.5 MLSLATNAALSAQS Unknown (immediate 
kidney stone early protein) - PIR2 
Accession 156046 
MFSIPEQFSSATKTNLEAQF Unknown - PIR2 
Accession A56046 
MLSLHTNAALSAQS Unknown - PIR2 
Accession 156046 
MLSLHTNAAAL(S)AQS Unknown - PIR2 
Accession 156046 
(D)VNGGGATLPQ(P)L YQ Unknown 
N. Calcium Phosphate 20% 67 XAHKSEVAHRFKDLGE Serum albumin 
(carbonate form) 
Calcium Phosphate 65% 5.6 43 MTPFMTEDFLLDTEFARRLY Unknown - PIR2 
(hydroxyl form) Accession A56045 
Protein 15% 5.1 32 AEVYNKDGNKLDLYGKVDGI Outer membrane 
kidney stone protein 
5.2 32.5 AEIYNKDGNKVDL YGKA VGL Outer membrane 
t All slightly different Accession D56046 
0 . CaOX = 80%; Uric acid = < 4.5 15 (Tryptic Digest) : 
10% (mono); NH3 Acid MLQSQLSQ(T)P-NH terminal 
Urate = 3% ; Protein = 4% fragment from stone P#78 
kidney stone 
P. CaOX = 18%; CaOX = XDVTGAGASFP 
64% ; (mono) (dihydrate) 
MgNH4P04 ·6H20 = 1 %; 5.2 33 .5 AEIYNKDGNKLDL YGKIDGL Outer membrane 
Ca10P04 = 6% protein 
Ca10(P04)6 = 7% ; 53 .3 A VINTNNLLSL TTQINNLNK 
Protein = 4% 
kidney stone < 4.5 14 TQSLHYSSPRETL TDTIMAA PIR2 
Accession F56046 
< 4.5 15 MLQSQLSQTPRLALADTVID PIR2 
Accession D56046 
Q. CaOx = 2% (mono); Uric 6.6 47.7 XXVT(T)DGADIVVKTK Porin-P 
acid = 95 % ; Protein = 3 % 
DVNGGGATLPQPL YQ Unknown same as 
M#49 
Accession A56045 
5.4 40 AVVGGGATLPEKLYGST Protein 3 - PIR2 
A56049 
4.8 29 (Q)GQGA VEGELFYKKQYNDSV Root adhesion protein 
B50H100 
Same as 6H61#8H69 
514 
Urinary stone proteins 
< 4.5 15 MLQSQLSQTPRLALADTVID (K5#46; #45 x-59; 
e#78; P6 - PIR2 
Accession D56046 
R. CaOx (mono) = 83%; 5.5 33.5 AE(M)YNKDGNKVDIYX 
CaP04 (carbonate form) = KVD MLXELEXAL 
3% 
CaP04 (hydroxyl) = 12% 4.9 30 AEVYNKDGNKDVYGKVD 
MLXELE(K)AL 
Protein = 2% 4.7 22 ML TELEKALNSIIDVYHKYS Calcium binding 
kidney stone < 4.0 10.5 MLXELEKALNXIID 
ML(T)ELEKALNXIIDVYHKY Calcium binding 
S. Bladder stone 5.5 33 .5 AEMYNKDGNKVDIYXKVD 
MgNH4P04 ·6H2O ML(T)ELEKALNS 
(struvite) = 50% 
Ca1cf0i3OH)6OH2O = 4.9 30 (1) Ratio of (1) to (2)-3 :2 
38% (carbonate apatite) AEVYNKDGNK(L)DVYGKVD 
(2) 
ML TELEKALNSIIXVY 
NH4H ·C5H2O3N4 ·H2O 4.75 22 ML TELEKALNSIIDVYHKYS Calcium binding 
= 7% ; Protein = 5% 
< 4.0 10.5 ML TELEKALNSIIDVYHKYS 
5 (l)ML(T)ELEKALN(S)IIDV Calcium binding 
(2)XKMXQXERNIE MRP-14 
6 MLXELEKALN (S)IIDVY 
T. Bladder stone 5.4 40 AVVGGGATLPEKLYGST Unknown• 
43 .5 XXVT(T)DGADTVVKTK Porin - P 
CaOX(monohydrate) = 2% < 4.5 15 MLQSQLSQTPRLALADTVID Unknown D56046 
Uric acid = 95% 4.8 29 (Q)GQGA VEGELFKKQYNDS Root adhesion 
Protein = 3% DVNGGGATLPEKKYGST Unknown 
U . Gallbladder stone 5.4 40 AVVGGGATLPEKLYGST • 
Cholesterol = 93 % ; 
Calcium bilirubinate = 4 % ; 
Mixed bile pigments = 3 % ; 
(Fraction II from AcA44 
column) 
t: contained serum amyloid p-component (SAP) and was obtained from a patient with Alzheimer's disease. 
t: Blocked. 
:j:: The Accession numbers, asterisk and PIR2 indicate NH-terminal sequences of new protein fragments which we have 
entered in the databank (Protein Information Resource, National Biomedical Research Foundation, Washington, DC). 
J.P. Binette et al. 
cell membranes and a few from bacterial cells. These 
findings are consistent with the presence of bacterial 
DNA in cholesterol gallstones [32] and the selectivity 
and diversity of matrix proteins. They also provide 
some evidence for the crystal injury of tubular epithelial 
cells early in stone formation [15]. 
A different matrix protein profile recently obtained 
by SDS gel electrophoresis of the pooled EDT A extracts 
of five types of kidney stones features albumin as the 
major component which is proposed as the protein that 
binds most other proteins to form the matrix of all 
stones [7]. This is a startling proposal which has the 
following limitations: (1) The authors, in order to gather 
enough material to study, pooled the stone extracts, thus 
excluding the possibility of detecting individual varia-
tions in composition; (2) SDS gel electrophoresis may 
have failed to detect differences in protein composition 
which could have been revealed by 2-D electrophoresis. 
This technique would probably have resolved the large 
protein component migrating as 67 kD on SDS gel elec-
trophoresis; (3) No mention is made of the residue after 
extraction; (4) Proteins considered by other investigators 
as major components of matrix are not reported. 
We can summarize the present state of knowledge 
of stone matrix proteins and "look into the seeds of time 
and say which grain will grow and which will not" [27] 
as follows: (1) The incorporation of proteins into the 
matrix is selective: not all urinary proteins are present 
nor are they democratically represented. (2) Considera-
ble evidence sustains the diversity of protein composition 
of stones of different types. (3) Stones, blood and tears 
appear to have special affinity . ( 4) Some proteins are 
shared by many stones but none is shared by all individ-
ual stones. (5) The presence of cell wall proteins in 
stones is consistent with tubular wall injury as crystals 
navigate the narrows of renal tubules or sink into the 
walls [15]. (6) The protein volume expansion induced 
by calcium binding may further impede the navigation of 
incipient stones. (7) The role of vitamin K in y-car-
boxyglutamic acid formation and calcium binding, and 
its inhibition by warfarin lead to interesting theoretical 
and therapeutic considerations. (8) The expanded devel-
opment of antisera may serve to visualize the distribution 
of specific proteins on the cut surface of the stone and 
to localize them in the renal tubule. (9) Local condi-
tions, such as, urine pH, specific ion concentration, de-
gree of hydration, and flow velocity may be important 
factors in stone formation, affecting the solubility and 
binding affinity of some proteins present in stones. (10) 
Some stone proteins may be intrinsically different 
through amino acid substitution, abnormal GLA forma-
tion, carboxylation or phosphorylation. 
Thus, the confluence of supersaturation with one or 
more favorable local conditions including eclectic protein 
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part1c1pation, cell wall injury and phagocytosis may 
result in the formation of a stone. 
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Discussion with Reviewers 
P.K. Grover: Though I agree that identification of ma-
trix proteins is essential to define their role in stone 
genesis, can the authors discuss or speculate as to why 
these proteins are there? 
Authors: Before the question concerning the role of 
proteins (matrix) in stone formation can be answered, 
J.P. Binette et al. 
proteins in stones should be extracted and characterized. 
The method of extraction has been reported in pre-
vious publications and it results in extensive recovery, so 
only a small portion of organic material remains that can 
be measured as protein. These extracts are concentrated 
by lyophilization or centricon centrifugation prior to iso-
electric focusing and, if adequate, 2-D electrophoresis. 
This method, besides its resolving power, allows micro-
sequencing of N-terminal amino acids or digestion of the 
polypeptide if the N-terminal is blocked. Proteins are 
finely characterized including isoelectric point and ap-
proximate molecular weight in a process which opens 
the possibilities of cloning and antisera production. 
The future of this approach appears brighter with 
the development of electrospray and laser desorption 
mass spectrometry combined with computer generated 
access to massive data and 2-D reproducible electrophor-
esis [39] . Such advances will be necessary to charac-
terize the proteome; study of urinary and stone proteins 
could be beneficiaries. However, this achievement will 
not provide knowledge of single protein function in 
urine, stones or cells but will expand the challenge to 
explain the role of the organic phase in stone formation. 
Difficulties include incomplete knowledge of the in-
teractions between proteins and Ca [40, 44], the altera-
tions in protein conformation and function brought about 
by variable environments, and the organization of pro-
teins into the matrix. Experiments have been designed 
to dissect these problems and investigate them in simpli-
fied systems with interesting results but incomplete ex-
planations. Increased complexity of experimental condi-
tions , such as reported by Lieske et al. [42, 43] and by 
Hammes et al. [41], whereby characterized chemical en-
tities may be tested in cell cultures, should expand the 
knowledge of the process of stone formation. The re-
cent development of a genetic model of urolithiasis in 
the rat may link the foreseen accomplishments in protein 
isolation and characterization with the genetics of the rat 
model, providing the means to study the proteins and 
gene(s) involved and their role in stone formation [38]. 
B. Hess: How do the authors explain why proteins ori-
ginating from cell membranes exclusively are present in 
stones containing struvite or carbonate apatite, i.e. , in 
stones formed by infection with urea-splitting bacteria? 
Authors: The most important urea splitting organisms 
are proteus, micrococcus urea, and aerobacter. Some 
strains of pseudomonas, klebsiella, providencia, serratia 
and staphylococcus are less frequent offenders. Certain 
strains of escherichia can form traces of ammonia. 
We found one sequence with partial homology with 
Porin P in a stone which contained 1 % struvite. The 
same sequence was in a stone with no struvite, only cal-
cium phosphate (in carbonate and in hydroxyl form). 
We think it likely that struvite stones acquire membrane 
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proteins through intimate cell contacts and are reminded 
that stones, including struvite stones, are not pure. 
K. Kohri: The authors identified many kinds of pro-
teins as stone matrix substances. However, the effect of 
these proteins on urinary stone formation is not known. 
I think that these proteins are mostly derived from mis-
cellaneous substances, such bacterial structure materials, 
substances adhered to stone surface, and urinary excre-
tion components. The authors have to describe the char-
acters and the actions of the identified matrix proteins. 
Also, we do not know what proteins are important 
for stone formation, because the matrix proteins are dif-
ferent in the same stone mineral components. 
Authors: We have determined the N-terminal sequences 
of a number of stones, not just ones given in Table 1. 
We have found MRP-14, calmodulin, serum amyloid P-
component, albumin, cal-protectin-like protein and sev-
eral with homology to thrombospondin, a widely distri-
buted protein. Upon submission to the data bank, the 
fourteen new sequences had no homologies with known 
proteins. Their accession numbers are listed in Table 1. 
Additional References 
[38] Bushinsky DA, Grynpas MD, Nilsson EL, 
Nakagawa Y, Coe FL (1995) Stone formation in genetic 
hypercalciuric rats. Kidney Int 48: 1705-1713. 
[39] Clauser KR, Hall SC, Smith DM, Webb JW, 
Andrews LE, Tran HM, Epstein LE, Burlingame Al 
(1995) Rapid mass spectrometric peptide sequencing and 
mass matching for characterization of human melanoma 
proteins isolated by two-dimensional electrophoresis. 
Proc Natl Acad Sci USA 92: 5072-5076. 
[40] Firouzi A, Kumar D, Bull LM, Besier T, 
Sieger P, Huo Q, Walker SA, Zasadzinski JA, Glinka 
C, Nicol J, Margolese D, Stucky GD, Chmelka BF 
(1995) Cooperative organization of inorganic surfactant 
and biomimetic assemblies. Science 267: 1138-1143. 
[41] Hammes MS, Lieske JC, Pawar S, Spargo BH, 
Toback FG (1995) Calcium oxalate monohydrate crystals 
stimulate gene expression in renal epithelial cells. Kid 
Inter 48: 501-509. 
[42] Lieske JC, Swift H, Martin T , Patterson B, 
Toback FG (1994) Renal epithelial cells rapidly bind and 
internalize calcium oxalate monohydrate crystals. Proc 
Natl Acad Sci USA 91: 6987-6991. 
[43] Lieske JC, Leonard R, Toback G (1995) Adhe-
sion of calcium oxalate monohydrate crystals to epithe-
lial cells is inhibited by specific anions. Am J Physiol 
268 (Renal Fluid Electrolyte Physiol 37): F604-F612. 
[44] Mann S, Archibald DD, Didymus JM, Douglas 
T, Heywood BR, Meldrum FC, Reeves NJ (1995) Crys-
tallization at inorganic-organic interfaces: Biominerals 
and biomimetic synthesis. Science 261: 1286-1292. 
